-+ 0.00%
-+ 0.00%
-+ 0.00%

Cantor Fitzgerald Reiterates Neutral on Pfizer, Maintains $27 Price Target

Benzinga·02/04/2026 16:19:08
Listen to the news
Cantor Fitzgerald analyst Carter Gould reiterates Pfizer (NYSE:PFE) with a Neutral and maintains $27 price target.